Cytotoxic agents in prostate cancer: an enigma.
D000135:Acid Phosphatase / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002945:Cisplatin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D004317:Doxorubicin; D003402:Creatine Kinase; D000135:Acid Phosphatase; D002945:Cisplatin